Showing results (1521-1530 of 6,770) with videos related to

Sort By:
Pageof 677
Clinical Therapeutics|April 28, 2015
Tolerability of Biphasic-Release Hydrocodone Bitartrate/Acetaminophen Tablets (MNK-155): A Phase III, Multicenter, Open-Label Study in Patients With Osteoarthritis or Chronic Low Back PainYanping Zheng, Kenneth Kostenbader, Thomas Barrett, et al.
Clinical Therapeutics|April 30, 2015
Asthma Treatments and Mental Health Visits After a Food and Drug Administration Label Change for Leukotriene InhibitorsChristine Y Lu, Fang Zhang, Matthew D Lakoma, et al.
Clinical Therapeutics|March 15, 2023
Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End PointsBrian E Lacy, Lin Chang, Satish S C Rao, et al.
Clinical Therapeutics|July 31, 2016
Antimicrobial Agent Dosing in InfantsJacob K Johnson, Matthew M Laughon
Clinical Therapeutics|July 25, 2016
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective DosingNikolas J Onufrak, Alan Forrest, Daniel Gonzalez
Clinical Therapeutics|June 8, 2015
Providing Quality Therapeutics in Switzerland: Role of the Stakeholders and Recent Incentives for Further ImprovementsMarie Besson, Caroline Samer, Victoria Rollason, et al.
Clinical Therapeutics|August 4, 2022
Survey of Health Care Provider Understanding of Gene Therapy Research for Inherited Metabolic DisordersJoyanna Hansen, Radha Ramachandran, Jerry Vockley
Clinical Therapeutics|April 29, 2021
Effect of Statin Therapy on the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients With Hyperlipidemia: A Proof-of-concept Observational StudyKaren Claesen, Joachim C Mertens, Shahir Basir, et al.
Clinical Therapeutics|February 25, 2023
The Impact of Highly Effective Cystic Fibrosis Transmembrane Conductance Regulator Modulators on the Health of Female Subjects With Cystic FibrosisJennifer L Taylor-Cousar, Michal Shteinberg, Malena Cohen-Cymberknoh, et al.
Clinical Therapeutics|September 13, 2021
In Vitro and Clinical Pharmacokinetic Studies of the Effects of Iron-containing Agents on Vadadustat, an Oral Hypoxia-inducible Factor-Prolyl Hydroxylase InhibitorYoshimasa Kokado, Kouji Kawai, Takehiro Nanjo, et al.
Pageof 677